Prot #TF-X0002-31: A Phase 3, Multicenter, Randomized, Placebo-controlled, Double-blind, 22-Week and 30-Week Open-label Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of X0002 Spray in Relief of the Pain for Subjects with Osteoarthritis of t

Project: Research project

Project Details

Effective start/end date10/15/2110/15/24


  • Premier Research International, LLC ((OE) Prot #TF-X0002-31 // (OE) Prot #TF-X0002-31)
  • Techfields, Inc. ((OE) Prot #TF-X0002-31 // (OE) Prot #TF-X0002-31)